Kalderos created the first platform for Drug Discount Management, leveraging an unprecedented amount of drug discount data and providing unprecedented clarity to every stakeholder. With AI & machine learning, we put data to work. And it’s all available in the cloud.

Sep 14, 2023 · We’re looking forward to working with you, and are happy to provide these downloadable logos. Please be respectful of our brand and avoid distorting or altering our logos in any way.

Kalderos created the world’s first Drug Discount Management platform, enabling drug discount stakeholders to collaborate with better data, transparency and trust.

On October 6, Kalderos filed suit against the U.S. Department of Health and Human Services (HHS) in regards to a change to longstanding policy in the 340B program.

Kalderos is a technology company focused on building trust, transparency and equity across the healthcare system. We work with all stakeholders - providers, payers, manufacturers and patients - to ensure the right discount to the right party on the right transaction℠.

After enrolling in MFA, the next time you visit app.kaleros.com, login using your email and password. From there, you’ll be prompted to enter a unique code (received via text or retrieved from your authentication app, depending on how you enrolled). After entering the code, click ‘Continue’ to access your account. This is the standard sign-on flow with MFA enabled.

Kalderos FAQs, HIPAA & Data Privacy, API Guide, and additional resources

Kalderos' drug discount management platform creates balance across healthcare stakeholders to support drug discount program compliance.

No, you are under no obligation to respond to claims in Kalderos Discount Hub. However, HRSA’s guidance is that manufacturers and covered entities should attempt to resolve suspected duplicate discounts in good faith.

Kalderos for Covered Entities offers safety net healthcare providers a single streamlined interface for responding to good faith inquiries, resolving Medicaid duplicate discounts and improving 340B program compliance.